Skip to main content Accessibility help
×
Home
  • Print publication year: 2010
  • Online publication date: February 2010

Section 3B - Description of muscle disease – specific diseases

References

1. E. P. Hoffman, Dystrophinopathies. In Disorders of Voluntary Muscle. Seventh Edition, eds. G. Karpati, D. Hilton-Jones, R. C. Griggs. (Cambridge, UK: Cambridge University Press, 2001), pp. 385–432.
2. G. B. A. Duchenne, Recherche sur la paralysie musculaire pseudo-hypertrophique ou paralysie myo-sclerotique. Arch. Gen. Med. 11 (1868), 5–25, 179–209, 305–321, 421–443, 552–588.
3. M. Eagle, J. Bourke, R. Bullock, et al., Managing Duchenne muscular dystrophy – the additive effect of spinal surgery and home nocturnal ventilation in improving survival. Neuromuscul. Disord. 17:6 (2007), 470–475.
4. J. Finsterer, C. Stollberger, The heart in human dystrophinopathies. Cardiology 99:1 (2003), 1–19.
5. J. M. de Kermadec, H. M. Becane, A. Chenard, F. Tertrain, Y. Weiss, Prevalence of left ventricular systolic dysfunction in Duchenne muscular dystrophy: an echocardiographic study. Am. Heart. J. 127:3 (1994), 618–623.
6. G. Corrado, A. Lissoni, S. Beretta, et al., Prognostic value of electrocardiograms, ventricular late potentials, ventricular arrhythmias, and left ventricular systolic dysfunction in patients with Duchenne muscular dystrophy. Am. J. Cardiol. 89:7 (2002), 838–841.
7. American Academy of Pediatrics Section on Cardiology and Cardiac Surgery, Cardiovascular health supervision for individuals affected by Duchenne or Becker muscular dystrophy. Pediatrics116:6 (2005), 1569–1573.
8. S. Cotton, N. J. Voudouris, K. M. Greenwood, Intelligence and Duchenne muscular dystrophy: full-scale, verbal, and performance intelligence quotients. Dev. Med. Child. Neurol. 43:7 (2001), 497–501.
9. D. A. Pillers, D. E. Bulman, R. G. Weleber, et al., Dystrophin expression in the human retina is required for normal function as defined by electroretinography. Nat. Genet. 4:1 (1993), 82–86.
10. A. E. Emery, Population frequencies of inherited neuromuscular diseases – a world survey. Neuromuscul. Disord. 1:1 (1991), 19–29.
11. A. E. Emery, R. Skinner, Clinical studies in benign (Becker type) X-linked muscular dystrophy. Clin. Genet. 10:4 (1976), 189–201.
12. M. Yazaki, K. Yoshida, A. Nakamura, et al., Clinical characteristics of aged Becker muscular dystrophy patients with onset after 30 years. Eur. Neurol. 42:3 (1999), 145–149.
13. K. M. Bushby, D. Gardner-Medwin, The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy. I. Natural history. J. Neurol. 240:2 (1993), 98–104.
14. K. Bushby, F. Muntoni, J. P. Bourke, 107th ENMC International Workshop: the management of cardiac involvement in muscular dystrophy and myotonic dystrophy 7th–9th June 2002, Naarden, the Netherlands. Neuromuscul. Disord. 13:2 (2003), 166–172.
15. E. M. Hoogerwaard, W. G. de Voogt, A. A. Wilde, et al., Evolution of cardiac abnormalities in Becker muscular dystrophy over a 13-year period. J. Neurol. 244:10 (1997), 657–663.
16. M. Saito, H. Kawai, M. Akaike, K. Adachi, Y. Nishida, S. Saito, Cardiac dysfunction with Becker muscular dystrophy. Am. Heart. J. 132:3 (1996), 642–647.
17. P. Melacini, M. Fanin, G. A. Danieli, et al., Cardiac involvement in Becker muscular dystrophy. J. Am. Coll. Cardiol. 22:7 (1993), 1927–1934.
18. G. Nigro, L. I. Comi, L. Politano, et al., Evaluation of the cardiomyopathy in Becker muscular dystrophy. Muscle Nerve 18:3 (1995), 283–291.
19. E. Kuhn, W. Fiehn, J. M. Schroder, H. Assmus, A. Wagner, Early myocardial disease and cramping myalgia in Becker-type muscular dystrophy: a kindred. Neurology 29:8 (1979), 1144–1149.
20. S. Eggers, V. Lauriano, M. Melo, et al., Why is the reproductive performance lower in Becker (BMD) as compared to limb girdle (LGMD) muscular dystrophy male patients?Am. J. Med. Genet. 60:1 (1995), 27–32.
21. L. Mestroni, M. Giacca, Molecular genetics of dilated cardiomyopathy. Curr. Opin. Cardiol. 12:3 (1997), 303–309.
22. P. Avner, E. Heard, X-chromosome inactivation: counting, choice and initiation. Nat. Rev. Genet. 2:1 (2001), 59–67.
23. L. Merlini, Calf myopathy with a twist. Neuromuscul. Disord. 4:1 (1994), 13–15.
24. S. D. Pena, G. Karpati, S. Carpenter, F. C. Fraser, The clinical consequences of X-chromosome inactivation: Duchenne muscular dystrophy in one of monozygotic twins. J. Neurol. Sci. 79:3 (1987), 337–344.
25. J. R. Lupski, C. A. Garcia, H. Y. Zoghbi, E. P. Hoffman, R. G. Fenwick, Discordance of muscular dystrophy in monozygotic female twins: evidence supporting asymmetric splitting of the inner cell mass in a manifesting carrier of Duchenne dystrophy. Am. J. Med. Genet. 40:3 (1991), 354–364.
26. P. Ferrier, F. Bamatter, D. Klein, Muscular dystrophy (Duchenne) in a girl with Turner's Syndrome. J. Med. Genet. 42 (1965), 38–46.
27. M. Zatz, A. M. Vianna-Morgante, P. Campos, A. J. Diament, Translocation (X;6) in a female with Duchenne muscular dystrophy: implications for the localisation of the DMD locus. J. Med. Genet. 18:6 (1981), 442–447.
28. E. M. Hoogerwaard, P. A. van der Wouw, A. A. Wilde, et al., Cardiac involvement in carriers of Duchenne and Becker muscular dystrophy. Neuromuscul. Disord. 9:5 (1999), 347–351.
29. L. Grain, M. Cortina-Borja, C. Forfar, D. Hilton-Jones, J. Hopkin, M. Burch, Cardiac abnormalities and skeletal muscle weakness in carriers of Duchenne and Becker muscular dystrophies and controls. Neuromuscul. Disord. 11:2 (2001), 186–191.
30. L. Politano, V. Nigro, G. Nigro, et al., Development of cardiomyopathy in female carriers of Duchenne and Becker muscular dystrophies. J. Am. Med. Assoc. 275:17 (1996), 1335–1338.
31. K. J. Felice, Distal weakness in dystrophin-deficient muscular dystrophy. Muscle Nerve 19:12 (1996), 1608–1610.
32. A. Prelle, R. Medori, M. Moggio, et al., Dystrophin deficiency in a case of congenital myopathy. J. Neurol. 239:2 (1992), 76–78.
33. F. J. Samaha, J. G. Quinlan, Myalgia and cramps: dystrophinopathy with wide-ranging laboratory findings. J. Child. Neurol. 11:1 (1996), 21–24.
34. N. Sunohara, K. Arahata, E. P. Hoffman, et al., Quadriceps myopathy: forme fruste of Becker muscular dystrophy. Ann. Neurol. 28:5 (1990), 634–639.
35. A. Morrone, E. Zammarchi, P. C. Scacheri, et al., Asymptomatic dystrophinopathy. Am. J. Med. Genet. 69:3 (1997), 261–267.
36. U. Francke, H. D. Ochs, B. de Martinville, et al., Minor Xp21 chromosome deletion in a male associated with expression of Duchenne muscular dystrophy, chronic granulomatous disease, retinitis pigmentosa, and McLeod syndrome. Am. J. Hum. Genet. 37:2 (1985), 250–267.
37. L. M. Kunkel, A. P. Monaco, W. Middlesworth, H. D. Ochs, S. A. Latt, Specific cloning of DNA fragments absent from the DNA of a male patient with an X chromosome deletion. Proc. Natl. Acad. Sci. U. S. A. 82:14 (1985), 4778–4782.
38. M. Koenig, E. P. Hoffman, C. J. Bertelson, A. P. Monaco, C. Feener, L. M. Kunkel, Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals. Cell 50:3 (1987), 509–517.
39. J. M. Murray, K. E. Davies, P. S. Harper, L. Meredith, C. R. Mueller, R. Williamson, Linkage relationship of a cloned DNA sequence on the short arm of the X chromosome to Duchenne muscular dystrophy. Nature 300:5887 (1982), 69–71.
40. H. M. Kingston, M. Sarfarazi, N. S. Thomas, P. S. Harper, Localisation of the Becker muscular dystrophy gene on the short arm of the X chromosome by linkage to cloned DNA sequences. Hum. Genet. 67:1 (1984), 6–17.
41. R. G. Worton, C. Duff, J. E. Sylvester, R. D. Schmickel, H. F. Willard, Duchenne muscular dystrophy involving translocation of the dmd gene next to ribosomal RNA genes. Science 224:4656 (1984), 1447–1449.
42. R. M. Greenstein, M. P. Reardon, T. S. Chan, et al., An (X;11) translocation in a girl with Duchenne muscular dystrophy Repository identification No GM1695. Cytogenet. Cell. Genet. 27:4 (1980), 268.
43. C. Verellen-Dumoulin, M. Freund, R. De Meyer, et al., Expression of an X-linked muscular dystrophy in a female due to translocation involving Xp21 and non-random inactivation of the normal X chromosome. Hum. Genet. 67:1 (1984), 115–119.
44. P. N. Ray, B. Belfall, C. Duff, et al., Cloning of the breakpoint of an X;21 translocation associated with Duchenne muscular dystrophy. Nature 318:6047 (1985), 672–675.
45. E. P. Hoffman, R. H. Brown Jr., L. M. Kunkel, Dystrophin: the protein product of the Duchenne muscular dystrophy locus. Cell 51:6 (1987), 919–928.
46. C. N. Tennyson, H. J. Klamut, R. G. Worton, The human dystrophin gene requires 16 hours to be transcribed and is cotranscriptionally spliced. Nat. Genet. 9:2 (1995), 184–190.
47. M. Koenig, A. P. Monaco, L. M. Kunkel, The complete sequence of dystrophin predicts a rod-shaped cytoskeletal protein. Cell 53:2 (1988), 219–228.
48. R. G. Hammonds, Jr., Protein sequence of DMD gene is related to actin-binding domain of alpha-actinin. Cell 51:1 (1987), 1.
49. R. A. Cross, M. Stewart, J. Kendrick-Jones, Structural predictions for the central domain of dystrophin. FEBS Lett. 262:1 (1990), 87–92.
50. X. Huang, F. Poy, R. Zhang, A. Joachimiak, M. Sudol, M. J. Eck, Structure of a WW domain containing fragment of dystrophin in complex with beta-dystroglycan. Nat. Struct. Biol. 7:8 (2000), 634–638.
51. C. P. Ponting, D. J. Blake, K. E. Davies, J. Kendrick-Jones, S. J. Winder, ZZ and TAZ: new putative zinc fingers in dystrophin and other proteins. Trends. Biochem. Sci. 21:1 (1996), 11–13.
52. D. J. Blake, J. M. Tinsley, K. E. Davies, A. E. Knight, S. J. Winder, J. Kendrick-Jones, Coiled-coil regions in the carboxy-terminal domains of dystrophin and related proteins: potentials for protein-protein interactions. Trends. Biochem. Sci. 20:4 (1995), 133–135.
53. A. Clerk, P. N. Strong, C. A. Sewry, Characterisation of dystrophin during development of human skeletal muscle. Development 114:2 (1992), 395–402.
54. A. A. Lev, C. C. Feener, L. M. Kunkel, R. H. Brown Jr., Expression of the Duchenne's muscular dystrophy gene in cultured muscle cells. J. Biol. Chem. 262:33 (1987), 15817–15820.
55. U. Nudel, K. Robzyk, D. Yaffe, Expression of the putative Duchenne muscular dystrophy gene in differentiated myogenic cell cultures and in the brain. Nature 331:6157 (1988), 635–638.
56. U. Nudel, D. Zuk, P. Einat, et al., Duchenne muscular dystrophy gene product is not identical in muscle and brain. Nature 337:6202 (1989), 76–78.
57. F. M. Boyce, A. H. Beggs, C. Feener, L. M. Kunkel, Dystrophin is transcribed in brain from a distant upstream promoter. Proc. Natl. Acad. Sci. U. S. A. 88:4 (1991), 1276–1280.
58. F. Muntoni, M. Cau, A. Ganau, et al., Brief report: deletion of the dystrophin muscle-promoter region associated with X-linked dilated cardiomyopathy. N. Engl. J. Med. 329:13 (1993), 921–925.
59. D. C. Gorecki, A. P. Monaco, J. M. Derry, A. P. Walker, E. A. Barnard, P. J. Barnard, Expression of four alternative dystrophin transcripts in brain regions regulated by different promoters. Hum. Mol. Genet. 1:7 (1992), 505–510.
60. H. Nishio, Y. Takeshima, N. Narita, et al., Identification of a novel first exon in the human dystrophin gene and of a new promoter located more than 500 kb upstream of the nearest known promoter. J. Clin. Invest. 94:3 (1994), 1037–1042.
61. V. N. D'souza, T. M. Nguyen, G. E. Morris, W. Karges, D. A. Pillers, P. N. Ray, A novel dystrophin isoform is required for normal retinal electrophysiology. Hum. Mol. Genet. 4:5 (1995), 837–842.
62. H. G. Lidov, S. Selig, L. M. Kunkel, Dp140: a novel 140 kDa CNS transcript from the dystrophin locus. Hum. Mol. Genet. 4:3 (1995), 329–335.
63. A. Bardoni, G. Felisari, M. Sironi, et al., Loss of Dp140 regulatory sequences is associated with cognitive impairment in dystrophinopathies. Neuromuscul. Disord. 10:3 (2000), 194–199.
64. T. J. Byers, H. G. Lidov, L. M. Kunkel, An alternative dystrophin transcript specific to peripheral nerve. Nat. Genet. 4:1 (1993), 77–81.
65. D. Rapaport, D. Lederfein, J. T. den Dunnen, et al., Characterization and cell type distribution of a novel, major transcript of the Duchenne muscular dystrophy gene. Differentiation 49:3 (1992), 187–193.
66. S. Bar, E. Barnea, Z. Levy, S. Neuman, D. Yaffe, U. Nudel, A novel product of the Duchenne muscular dystrophy gene which greatly differs from the known isoforms in its structure and tissue distribution. Biochem. J. 272:2 (1990), 557–560.
67. M. P. Moizard, A. Toutain, D. Fournier, et al., Severe cognitive impairment in DMD: obvious clinical indication for Dp71 isoform point mutation screening. Eur. J. Hum. Genet. 8:7 (2000), 552–556.
68. D. Lederfein, Z. Levy, N. Augier, et al., A 71-kilodalton protein is a major product of the Duchenne muscular dystrophy gene in brain and other nonmuscle tissues. Proc. Natl. Acad. Sci. U. S. A. 89:12 (1992), 5346–5350.
69. J. M. Tinsley, D. J. Blake, K. E. Davies, Apo-dystrophin-3: a 2.2kb transcript from the DMD locus encoding the dystrophin glycoprotein binding site. Hum. Mol. Genet. 2:5 (1993), 521–524.
70. E. A. Burton, J. M. Tinsley, P. J. Holzfeind, N. R. Rodrigues, K. E. Davies, A second promoter provides an alternative target for therapeutic up-regulation of utrophin in Duchenne muscular dystrophy. Proc. Natl. Acad. Sci. U. S. A. 96:24 (1999), 14025–14030.
71. D. R. Love, D. F. Hill, G. Dickson, et al., An autosomal transcript in skeletal muscle with homology to dystrophin. Nature 339:6219 (1989), 55–58.
72. J. Wilson, W. Putt, C. Jimenez, Y. H. Edwards, Up71 and up140, two novel transcripts of utrophin that are homologues of short forms of dystrophin. Hum. Mol. Genet. 8:7 (1999), 1271–1278.
73. D. J. Blake, J. N. Schofield, R. A. Zuellig, et al., G-utrophin, the autosomal homologue of dystrophin Dp116, is expressed in sensory ganglia and brain. Proc. Natl. Acad. Sci. U. S. A. 92:9 (1995), 3697–3701.
74. G. Karpati, S. Carpenter, G. E. Morris, K. E. Davies, C. Guerin, P. Holland, Localization and quantitation of the chromosome 6-encoded dystrophin-related protein in normal and pathological human muscle. J. Neuropathol. Exp. Neurol. 52:2 (1993), 119–128.
75. A. O. Gramolini, J. Wu, B. J. Jasmin, Regulation and functional significance of utrophin expression at the mammalian neuromuscular synapse. Microsc. Res. Tech. 49:1 (2000), 90–100.
76. F. Galvagni, M. Cantini, S. Oliviero, The utrophin gene is transcriptionally up-regulated in regenerating muscle. J. Biol. Chem. 277:21 (2002), 19106–19113.
77. M. Pearce, D. J. Blake, J. M. Tinsley, et al., The utrophin and dystrophin genes share similarities in genomic structure. Hum. Mol. Genet. 2:11 (1993), 1765–1772.
78. S. J. Winder, L. Hemmings, S. K. Maciver, et al., Utrophin actin binding domain: analysis of actin binding and cellular targeting. J. Cell. Sci. 108:Pt 1 (1995), 63–71.
79. K. J. Amann, A. W. Guo, J. M. Ervasti, Utrophin lacks the rod domain actin binding activity of dystrophin. J. Biol. Chem. 274:50 (1999), 35375–35380.
80. S. J. Winder, T. J. Gibson, J. Kendrick-Jones, Dystrophin and utrophin: the missing links!FEBS Lett. 369:1 (1995), 27–33.
81. J. A. Rafael, J. M. Tinsley, A. C. Potter, A. E. Deconinck, K. E. Davies, Skeletal muscle-specific expression of a utrophin transgene rescues utrophin-dystrophin deficient mice. Nat. Genet. 19:1 (1998), 79–82.
82. J. R. Deol, G. Danialou, N. Larochelle, et al., Successful compensation for dystrophin deficiency by a helper-dependent adenovirus expressing full-length utrophin. Mol. Ther. 15:10 (2007), 1767–1774.
83. A. E. Deconinck, J. A. Rafael, J. A. Skinner, et al., Utrophin-dystrophin-deficient mice as a model for Duchenne muscular dystrophy. Cell 90:4 (1997), 717–727.
84. J. D. Porter, J. A. Rafael, R. J. Ragusa, J. K. Brueckner, J. I. Trickett, K. E. Davies, The sparing of extraocular muscle in dystrophinopathy is lost in mice lacking utrophin and dystrophin. J. Cell. Sci. 111:Pt 13 (1998), 1801–1811.
85. M. P. Chevron, B. Echenne, J. Demaille, Absence of dystrophin and utrophin in a boy with severe muscular dystrophy. N. Engl. J. Med. 331:17 (1994), 1162–1163.
86. G. Karpati, R. Gilbert, B. J. Petrof, J. Nalbantoglu, Gene therapy research for Duchenne and Becker muscular dystrophies. Curr. Opin. Neurol. 10:5 (1997), 430–435.
87. P. Miura, B. J. Jasmin, Utrophin upregulation for treating Duchenne or Becker muscular dystrophy: how close are we?Trends Mol. Med. 12:3 (2006), 122–129.
88. R. C. Hirst, K. J. McCullagh, K. E. Davies, Utrophin upregulation in Duchenne muscular dystrophy. Acta. Myol. 24:3 (2005), 209–216.
89. K. P. Campbell, J. T. Stull, Skeletal muscle basement membrane-sarcolemma-cytoskeleton interaction minireview series. J. Biol. Chem. 278:15 (2003), 12599–12600.
90. V. Straub, K. P. Campbell, Muscular dystrophies and the dystrophin-glycoprotein complex. Curr. Opin. Neurol. 10:2 (1997), 168–175.
91. U. Mayer, Integrins: redundant or important players in skeletal muscle?J. Biol. Chem. 278: